What conditions does Exelixis run trials for?

In our tracked recruiting trials, Exelixis sponsors trials for Breast cancer, Lung cancer, Pancreatic cancer.

Clinical trials sponsored by Exelixis

Exelixis is the lead sponsor of 4 recruiting trials in our tracked data.

Recruiting trials

Conditions studied

Phase 1 3Phase 2 1Phase 3 1

Condition	Trials
Breast cancer	2
Lung cancer	2
Pancreatic cancer	2
Prostate cancer	2
Advanced Solid Tumor	1
Clear Cell Renal Cell Carcinoma (ccRCC)	1
Colorectal Cancer (CRC)	1
Colorectal cancer	1
Drug-Drug Interaction (DDI)	1
Esophageal Squamous Cell Cancer	1
Extra-Pancreatic Neuroendocrine Tumor (epNET)	1
Head and Neck Squamous Cell Cancer	1
Head and Neck Squamous Cell Carcinoma (HNSCC)	1
Hepatocellular Carcinoma (HCC)	1
Hormone-receptor-positive Breast Cancer	1

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
Study of XB010 in Subjects With Solid Tumors
NCT06545331 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 124 locations